In pancreatic ductal adenocarcinoma (PDAC), elevated MARS1 expression correlates with poor prognosis, and in our previous study, it was identified—alongside lymph node metastasis—as an independent predictor of unfavorable outcomes in PDAC patients [14]. This evidence concerns the gene MARS1 and pancreatic ductal adenocarcinoma.